Drugs / tafluprost/timolol
last change Jul 2018 re-read 3 minutes ago

tafluprost/timolol

Developed for
open-angle glaucoma

Trials 0

PhaseRegistry idDatesIndicationSponsorStatusOutcome
Comparator or background therapy1 trial
Phase 4 NCT03612817 Comparator Jan 2017 → Apr 2018 open-angle glaucoma Aristotle University Of Thessaloniki Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as tafluprost/timolol ClinicalTrials.gov intervention name — accepted as the source's own label NCT03612817 ↗